Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sight Sciences (SGHT) Share-based Compensation (2020 - 2025)

Historic Share-based Compensation for Sight Sciences (SGHT) over the last 6 years, with Q3 2025 value amounting to $2.4 million.

  • Sight Sciences' Share-based Compensation fell 4380.22% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.5 million, marking a year-over-year decrease of 1289.86%. This contributed to the annual value of $17.1 million for FY2024, which is 1711.82% up from last year.
  • As of Q3 2025, Sight Sciences' Share-based Compensation stood at $2.4 million, which was down 4380.22% from $3.8 million recorded in Q2 2025.
  • Sight Sciences' 5-year Share-based Compensation high stood at $4.5 million for Q1 2024, and its period low was $300000.0 during Q1 2021.
  • Moreover, its 5-year median value for Share-based Compensation was $3.5 million (2023), whereas its average is $3.2 million.
  • Its Share-based Compensation has fluctuated over the past 5 years, first skyrocketed by 133230.77% in 2021, then tumbled by 4380.22% in 2025.
  • Over the past 5 years, Sight Sciences' Share-based Compensation (Quarter) stood at $2.0 million in 2021, then soared by 63.66% to $3.2 million in 2022, then rose by 6.99% to $3.5 million in 2023, then rose by 14.05% to $3.9 million in 2024, then crashed by 38.65% to $2.4 million in 2025.
  • Its last three reported values are $2.4 million in Q3 2025, $3.8 million for Q2 2025, and $4.2 million during Q1 2025.